MONICA AERSTIN: Open Payments
NPI 1326199712 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 17 payments from 6 companies in 2025. Trend: 2023 $252 · 2024 $249 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $211 |
| Abbott Laboratories | 1 | $137 |
| PFIZER INC. | 4 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| CVRx, Inc. | 3 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: CARDIOMEMS, WAINUA, VYNDAQEL, JARDIANCE, Barostim Neo System, Kerendia.
Industry payments across GA — which companies pay providers there.
